Credence Research Logo
Inquiry Before Buying
Home » Healthcare » Cell & Gene Therapy Clinical Trials Market

Cell & Gene Therapy Clinical Trials Market By Indication (Oncology, Genetic Disorders, Cardiovascular Disorders, Neurological Disorders, Infectious Diseases, Others) By Phase of Clinical Trials (Phase 1, Phase 2, Phase 3)-Growth, Future Prospects & Competitive Analysis, 2016 – 2030

Price: $4999

Published: | Report ID: 21604 | Report Format : PDF

Market Insights

  • The global demand for Cell & Gene Therapy Clinical Trials was valued at USD 8354.9 Million in 2022 and is expected to reach USD 26096.1 Million in 2030, growing at a CAGR of 15.30% between 2023 and 2030.
  • The Cell Therapy category is the market’s dominant section, and Gene Therapy is another prominent area that contributes significantly to the market share of the Cell & Gene Therapy Clinical Trials Market.
  • The oncology sector will dominate the global market with a revenue share of more than 47.1% in 2022, while the Cardiovascular Disorders category will be the fastest growing.
  • In 2022, the Phase II category is expected to lead the global market, accounting for more than 53% of total revenue, while the Phase I sector is expected to have a big share of 14.8%.0
  • The Randomized Controlled Trials (RCTs) sector has a higher Compound Annual Growth Rate (CAGR), while non-randomized trials are another high-demand area in the industry.
  • Pediatric Patients are the industry’s fastest growing segment, while Adult Patients have the highest market demand.
  • In 2022, North America represented for 48.4% of worldwide sales and is predicted to maintain its dominance throughout the forecast period, with Asia Pacific growing at the fastest CAGR of 15.6%.
  • Rising private and public investments, an increase in the prevalence of cardiovascular illness, and advancements in gene editing and cell therapy technologies are the key drivers od the market.
  • Stringent regulatory requirements, high research and development expenditures, and limited scalability and production constraints

Cell & Gene Therapy Clinical Trials Market

Executive Summary

Market Definition

The cell & gene therapy clinical studies market is the industry that conducts clinical studies for cell and gene therapies. These therapies employ living cells or genetic material to treat a variety of diseases and medical issues. The market encompasses these therapies’ research, development, and testing to determine their safety and efficacy in treating patients. It is a developing field with tremendous promise for medical treatment breakthroughs.

Design Element 2

Access crucial information at unmatched prices!

Request your free sample report today & start making informed decisions powered by Credence Research!

Download Free Sample
CTA Design Element 3

Market Overview

The global cell & gene therapy clinical trials market has been steadily growing in recent years and is predicted to develop at a 15.30% CAGR between 2023 and 2030. In 2022, the market was valued at USD 8354.9 million, and it is predicted to grow to USD 26096.1 million by 2030.

The cell & gene therapy clinical trials market is a fast growing business that focuses on conducting clinical trials for novel medicines using living cells and genetic material. Several reasons drive this market. For example, there is a growing need for personalized medicine, in which therapies are tailored to specific patients based on their genetic composition. Furthermore, developments in manufacturing and delivery technologies have increased the viability and scalability of cell and gene therapies. Furthermore, private and public funding in this industry have increased, boosting research and development initiatives.

However, there are several limitations in this industry. Companies seeking approval for these therapies may face difficulties due to the complicated and dynamic regulatory landscape. Furthermore, the high cost of development and manufacture, as well as the requirement for specialized infrastructure and knowledge, might constitute entry hurdles. Despite these obstacles, the Cell & Gene Therapy Clinical Trials Market offers considerable opportunity for medical treatment breakthroughs and has the potential to transform healthcare.

Segmentation by Therapy Type

  • The cell therapy category is the market’s dominant segment. It entails the use of live cells in the treatment of diseases and medical problems. It has attracted significant attention and investment as a result of developments in cell therapy techniques and successful clinical trials.
  • Gene Therapy is another major segment that adds significantly to the Cell & Gene Therapy Clinical Trials Market’s market share. It entails using genetic material to treat diseases by changing or replacing defective genes.

Segmentation by Indication

  • The oncology sector is expected to rise at a CAGR of 15.0% over the forecast period, dominating the global market with a revenue share of more than 47.1% in 2022.
  • The Cardiovascular Disorders category is the fastest expanding. The growing global frequency of cardiovascular illnesses has produced a substantial need for novel therapeutics.

Segmentation by Phase of Clinical Trials

  • The phase II category dominated the global market in 2022, accounting for more than 53% of total revenue, as the majority of cell and gene therapies are in this stage of the clinical trial.
  • The majority of cell and gene therapy studies are now failing to advance to the next stage of research. This leads to the sector market’s largest share. In 2022, the Phase I sector is predicted to have a large share of 14.8.

Segmentation by Trial Design

  • The Randomized Controlled Trials (RCTs) sector has a higher Compound Annual Growth Rate (CAGR). RCTs are often regarded as the gold standard for assessing the safety and efficacy of new treatments.
  • Another high-demand area in the Cell & Gene Therapy Clinical Trials Market is non-randomized trials.

Segmentation by Patient Age

  • Pediatric Patients are the fastest increasing sector in the Cell & Gene Therapy Clinical Trials Market.
  • Adult Patients are the sector with the biggest market demand in the Cell & Gene Therapy Clinical Trials Market. As cell and gene therapies progress, there is a greater emphasis on finding treatments for adult patients.

Segmentation by Region

  • In 2022, North America accounted for 48.4% of global sales and is expected to maintain its lead throughout the projection period.
  • During the projection period, Asia Pacific is expected to grow at the quickest CAGR of 15.6%.
  • The rest of the world, including Latin America, the Middle East, and Africa, supplies the remaining demand for Cell & Gene Therapy Clinical Trials.

Cell & Gene therapy clinical trials market regional analysis

The rising prevalence of cardiovascular disease promotes market expansion. There is a higher demand for creative and effective therapeutic solutions as the number of people suffering from cardiovascular diseases grows. Cell and gene therapies offer long-term hope by targeting the root causes of cardiovascular disease.

North America accounted for 48.4% of worldwide sales in 2022 and is predicted to maintain its lead throughout the projection period. This is due to a favourable regulatory framework, particularly in the United States. The FDA in the United States has designed a collaborative regulatory method for CGTs that includes early and consistent involvement with the sponsor, as well as unique regulatory designations that are useful for many CGTs. Furthermore, the regulatory approval procedure in the United States is improving and becoming more favourable to vendors producing CGT goods. To speed the clearance process, the FDA is designating CGTs with orphan drug status, breakthrough designation, accelerated approvals, and RMAT designations.

During the projection period, Asia Pacific is expected to grow at the quickest CAGR of 15.6%. on the Asia Pacific region, a growing number of biotechnology enterprises are focusing on regenerative treatments. Furthermore, with the continued expansion of medical tourism destinations such as Thailand, Singapore, and India, the area is expected to maintain its position as the epicentre of cell research and therapy. Furthermore, Asian enrollment for CGT clinical trials is growing in comparison to North America and Europe. This is owing to the big patient pool and low trial cost; this enhances the Asia Pacific market even further.

Key Highlights of the Report

The global Cell & Gene Therapy Clinical Trials Market is segmented by Therapy Type, Indication, Phase of Clinical Trialss, Trial Design, Patient Age. The phase II trial and Cell Therapy type segments  dominate the global market. Also  Pediatric Patients and Cardiovascular Disorders category are the fastest expanding segments. The Randomized Controlled Trials (RCTs) sector has a higher (CAGR), with North America leading the market growth.

Rising private and public investments, as well as an increase in the prevalence of cardiovascular disease, are the key market drivers. Stringent regulatory restrictions, significant R&D costs, and restricted scalability and production constraints. Furthermore, the market’s important opportunities include increased applications in several therapeutic areas, rising demand for personalized medicine, and the opportunity for international collaborations and partnerships.

Nonetheless, North America is expected to maintain its lead throughout the projected period, accounting for 48.4% of global sales in 2022. This is because of a supportive regulatory environment, particularly in the United States. In addition, Asia Pacific is predicted to develop at the fastest rate, with a CAGR of 15.6%. A rising number of biotechnology companies in the Asia Pacific area are concentrating on regenerative medicines.

What Are The Factors That Are Driving The Growth Of The Global Cell & Gene Therapy Clinical Trials Market?

The primary drivers of the market include rising private and public investments, an increase in the prevalence of cardiovascular illness, and advancements in gene editing and cell therapy technologies.

What Challenges Does The Global Cell & Gene Therapy Clinical Trials Market Face?

Stringent regulatory requirements, high research and development expenditures, and limited scalability and production constraints

What Growth Opportunities Are Available In The Global Cell & Gene Therapy Clinical Trials Market?

The market’s significant opportunities include expanding applications in numerous therapeutic areas, rising demand for personalized medicine, and the potential for international collaborations and partnerships.

Market Drivers

The global Cell & Gene Therapy Clinical Trials Market is driven by several factors. The following are the key drivers of the global Cell & Gene Therapy Clinical Trials Market:

Increased Prevalence Of Cardiovascular Disease

With an increasing number of people suffering from cardiovascular diseases, there is a greater demand for novel and effective therapeutic solutions. Cell and gene therapies provide promise long-term remedies by addressing the fundamental causes of cardiovascular disease. As a result, private and public funding in research and development of these medicines have increased dramatically. Cell and gene therapy clinical trials for cardiovascular illnesses aim to enhance patient outcomes, reduce disease burden, and, ultimately, revolutionize the treatment landscape. The prevalence of cardiovascular illness works as a driving force, promoting improvements in the Cell & Gene Therapy Clinical Trials Market and fueling the development of potentially life-changing remedies for people suffering from these conditions.

Market Restraints

The global Cell & Gene Therapy Clinical Trials Market faces some challenges that may hinder its growth. These include the following:

High Costs

Cell and gene therapy development and execution are complex procedures that include research, manufacturing, and clinical trials. These methods necessitate considerable financial commitments, making these medicines prohibitively expensive for patients, healthcare providers, and payers. The high expense of cell and gene therapy clinical trials can limit accessibility and affordability, making it difficult for patients to obtain these cutting-edge treatments.

Furthermore, the high cost places a strain on healthcare systems and payers, who must determine the cost-effectiveness of these medicines. Efforts are being made to alleviate this constraint by investigating cost-cutting solutions and encouraging stakeholder participation. These programs attempt to cut prices, enhance patient access, and make cell and gene therapies more affordable and commercially viable.

Opportunities

The global Cell & Gene Therapy Clinical Trials Market offers significant growth opportunities. These include the following:

Increasing Private And Public Investments

As more private investors and government institutions see the enormous promise of cell and gene therapies, more resources are being allocated to research, development, and commercialization activities. Private investments, such as venture capital funding and collaborations with pharmaceutical corporations, provide critical financial support for the advancement of clinical studies, the improvement of manufacturing processes, and the maintenance of regulatory compliance.

Similarly, public investments, such as government grants and research institution funding, help to enhance scientific knowledge, promote academic research, and build specialized infrastructure. The infusion of private and public funding not only fuels innovation but also promotes collaboration among academia, industry, and regulatory organizations. This alliance encourages knowledge exchange, regulatory improvements, and standardization, hence establishing a favourable climate for the development and availability of transformative cell and gene therapies.

Competitive Landscape

Cell & Gene Therapy Clinical Trials Market key insights

Key Players

The global Cell & Gene Therapy Clinical Trials Market is highly competitive, with several key players. Some of the major players in the market and their market share are as follows:

  • IQVIA
  • ICON Plc
  • Laboratory Corporation of America Holdings
  • Charles River Laboratories International, Inc.
  • PAREXEL International Corp.
  • Syneos Health
  • Medpace, Holdings, Inc.
  • PPD Inc.
  • Novotech
  • Veristat, LLC

These organizations prioritize product innovation, Patient Age  expansion, and mergers and acquisitions to stay competitive.

The global Cell & Gene Therapy Clinical Trials Market’s key players continually seek to stay ahead by offering new products and developments.

In January 2020, HemaCare Corp., a major producer of human-derived cellular commodities for the cell therapy market, was purchased by Charles River Laboratory for USD 380 million in cash.

In March 2021, Amgen Inc., a multinational biopharmaceutical firm based in the United States, and Rodeo Therapeutics Corporation, a biotechnology business, announced a deal in which Amgen will acquire Rodeo, which develops small-molecule medicines to enhance regeneration and repair of different tissues. The collaboration would aid the company’s growth by combining Rodeo’s 15-PGDH (prostaglandin-degrading enzyme) program with Amgen’s inflammation portfolio.

In June 2021, CyGenica, a biotechnology startup, said that it has raised US$ 1.4 billion in a seed fund investment round sponsored by SOS, a non-governmental organization. The funding round will help CyGenica’s unique technology for safe, targeted, and cheap intercellular drug delivery gain traction. The funding would hasten the development of innovative drug delivery technology in the improvement of therapies for cancer and rare disorders, thereby improving the health and quality of life of patients.

Shape Your Report to Specific Countries or Regions & Enjoy 30% Off!

Customize Now

Summary of Key Findings

  • increased prevalence of cardiovascular disease drives market expansion
  • Market segmented by Therapy Type, Indication, Phase of Clinical Trialss, Indication, Trial Design, Phase of Clinical Trials, Patient Age  and region.
  • The phase II category dominated the global market in 2022, accounting for more than 53% of total revenue, as the majority of cell and gene therapies are in this stage of the clinical trial
  • Randomized Controlled Trials (RCTs) sector has a higher Compound Annual Growth Rate (CAGR)
  • North America is leading market growth; the market is highly competitive with key players including IQVIA; ICON Plc; Laboratory Corporation of America Holdings; PAREXEL International Corp.; Charles River Laboratories International, Inc.; Syneos Health; PPD Inc.; Medpace, Holdings, Inc.; Novotech; Veristat, LLC, and others

Future Outlook

  • Increasing emphasis on individualized medicine
  • Gene editing technology developments
  • Clinical trial infrastructure expansion
  • Increasing alliances and partnerships
  • Regulatory advancements and shortened licensing processes

Segmentation

  • By Therapy Type:
    • Cell Therapy
      • Autologous Cell Therapy
      • Allogeneic Cell Therapy
    • Gene Therapy
      • In Vivo Gene Therapy
      • Ex Vivo Gene Therapy
    • By Indication:
      • Oncology
      • Genetic Disorders
      • Cardiovascular Disorders
      • Neurological Disorders
      • Infectious Diseases
      • Others
    • By Phase of Clinical Trials:
      • Phase 1
      • Phase 2
      • Phase 3
    • By Trial Design:
      • Randomized Controlled Trials (RCTs)
      • Non-Randomized Trials
    • By Patient Age:
      • Pediatric Patients
      • Adult Patients
    • By Region
      • North America
        • U.S
        • Canada
        • Mexico
      • Europe
        • Germany
        • France
        • U.K.
        • Italy
        • Spain
        • Rest of Europe
      • Asia Pacific
        • China
        • Japan
        • India
        • South Korea
        • South-east Asia
        • Rest of Asia Pacific
      • Latin America
        • Brazil
        • Argentina
        • Rest of Latin America
      • Middle East & Africa
        • GCC Countries
        • South Africa
        • Rest of Middle East and Africa

Adjacent Markets

In the Cell & Gene Therapy Clinical Trials Market, there are several adjacent markets which has high revenue growth opportunities. The key adjacent markets for Cell & Gene Therapy Clinical Trials Market –

Cell & Gene Therapy Clinical Trials Market Adjacent Market

1. Preface

1.1. Report Description

1.1.1. Purpose of the Report

1.1.2. Target Audience

1.1.3. USP and Key Offerings

1.2. Research Scope

1.3. Market Introduction

 

2. Executive Summary

2.1. Market Snapshot: Global Cell & Gene Therapy Clinical Trials Market

2.1.1. Global Cell & Gene Therapy Clinical Trials Market, By Therapy Type

2.1.2. Global Cell & Gene Therapy Clinical Trials Market, By Indication

2.1.3. Global Cell & Gene Therapy Clinical Trials Market, By Phase of Clinical Trials

2.1.4. Global Cell & Gene Therapy Clinical Trials Market, By Trial Design

2.1.5. Global Cell & Gene Therapy Clinical Trials Market, By Patient Age

2.1.6. Global Cell & Gene Therapy Clinical Trials Market, By Region

2.2. Insights from Primary Respondents

 

3. Market Dynamics & Factors Analysis

3.1. Introduction

3.1.1. Global Cell & Gene Therapy Clinical Trials Market Value, 2017-2030, (US$ Mn)

3.1.2. Y-o-Y Growth Trend Analysis

3.2. Market Dynamics

3.2.1. Cell & Gene Therapy Clinical Trials Market Drivers

3.2.2. Cell & Gene Therapy Clinical Trials Market Restraints

3.2.3. Cell & Gene Therapy Clinical Trials Market Opportunities

3.2.4. Major Cell & Gene Therapy Clinical Trials Industry Challenges

3.3. Growth and Development Patterns

3.4. Investment Feasibility Analysis

3.5. Market Opportunity Analysis

3.5.1. Therapy Type

3.5.2. Indication

3.5.3. Phase of Clinical Trials

3.5.4. Trial Design

3.5.5. Patient Age

3.5.6. Sales Channel

3.5.7. Price Range

3.5.8. Geography

 

4. Market Competitive Landscape Analysis

4.1. Company Market Share Analysis, 2022

4.1.1. Global Cell & Gene Therapy Clinical Trials Market: Company Market Share, Value 2022

4.1.2. Global Cell & Gene Therapy Clinical Trials Market: Top 6 Company Market Share, Value 2022

4.1.3. Global Cell & Gene Therapy Clinical Trials Market: Top 3 Company Market Share, Value 2022

4.2. Global Cell & Gene Therapy Clinical Trials Market: Company Revenue Share Analysis, 2022

4.3. Company Assessment Metrics, 2022

4.3.1. Stars

4.3.2. Emerging Leaders

4.3.3. Pervasive Players

4.3.4. Participants

4.4. Startups/ SMEs Assessment Metrics, 2022

4.4.1. Progressive Companies

4.4.2. Responsive Companies

4.4.3. Dynamic Companies

4.4.4. Starting Blocks

4.5. Strategic Development

4.5.1. Acquisition and Mergers

4.5.2. New Product Launch

4.5.3. Regional Expansion

4.5.4. Partnerships

4.6. Key Player Product Matrix

4.7. Potential for New Players in the Global Cell & Gene Therapy Clinical Trials Market

 

5. Premium Insights

5.1. STAR (Situation, Task, Action, Results) Analysis

5.2. Porter’s Five Forces Analysis

5.2.1. Threat of New Entrants

5.2.2. Bargaining Power of Buyers/Consumers

5.2.3. Bargaining Power of Suppliers

5.2.4. Threat of Substitute Types

5.2.5. Intensity of Competitive Rivalry

5.3. PESTEL Analysis

5.3.1. Political Factors

5.3.2. Economic Factors

5.3.3. Social Factors

5.3.4. Technological Factors

5.3.5. Environmental Factors

5.3.6. Legal Factors

5.4. Key Market Trends

5.4.1. Demand Side Trends

5.4.2. Supply Side Trends

5.5. Value Chain Analysis

5.6. Technology Analysis

5.6.1. Research and development in the global market

5.6.2. Patent Analysis

5.6.3. Emerging technologies and their potential disruption to the market

5.7. Consumer Behaviour Analysis

5.7.1. Consumer Preferences and Expectations

5.7.2. Factors Influencing Consumer Buying Decisions

5.7.2.1. North America

5.7.2.2. Europe

5.7.2.3. Asia Pacific

5.7.2.4. Latin America

5.7.2.5. Middle East and Africa

5.7.3. Consumer Pain Points

5.8. Analysis and Recommendations

5.9. Adjacent Market Analysis

 

6. Market Positioning of Key Players, 2022

6.1. Company market share of key players, 2022

6.2. Competitive Benchmarking

6.3. Market Positioning of Key Vendors

6.4. Geographical Presence Analysis

6.5. Major Strategies Adopted by Key Players

6.5.1. Key Strategies Analysis

6.5.2. Mergers and Acquisitions

6.5.3. Partnerships

6.5.4. Product Launch

6.5.5. Geographical Expansion

6.5.6. Others

 

7. Impact Analysis of COVID 19 and Russia – Ukraine War on Cell & Gene Therapy Clinical Trials Market

7.1. Ukraine-Russia War Impact

7.1.1. Uncertainty and Economic Instability

7.1.2. Supply chain disruptions

7.1.3. Regional market shifts

7.1.4. Shift in government priorities

7.2. COVID-19 Impact Analysis

7.2.1. Supply Chain Disruptions

7.2.2. Demand Fluctuations

7.2.3. Shift in Product Mix

7.2.4. Reduced Industrial Activity

7.2.5. Regional Impact Analysis

7.2.5.1. North America

7.2.5.2. Europe

7.2.5.3. Asia Pacific

7.2.5.4. Latin America

7.2.5.5. Middle East and Africa

 

8. Global Cell & Gene Therapy Clinical Trials Market, By Therapy Type

8.1. Global Cell & Gene Therapy Clinical Trials Market Overview, By Therapy Type

8.1.1. Global Cell & Gene Therapy Clinical Trials Market Revenue Share, By Therapy Type, 2022 Vs 2030 (in %)

8.2. Cell Therapy

8.2.1. Global Cell & Gene Therapy Clinical Trials Market, By CELL THERAPY, By Region, 2017-2030 (US$ Mn)

8.2.2. Market Dynamics for CELL THERAPY

8.2.2.1. Drivers

8.2.2.2. Restraints

8.2.2.3. Opportunities

8.2.2.4. Trends

8.3. Gene Therapy

8.3.1. Global Cell & Gene Therapy Clinical Trials Market, By GENE THERAPY, By Region, 2017-2030 (US$ Mn)

8.3.2. Market Dynamics for GENE THERAPY

8.3.2.1. Drivers

8.3.2.2. Restraints

8.3.2.3. Opportunities

8.3.2.4. Trends

 

9. Global Cell & Gene Therapy Clinical Trials Market, By Indication

9.1. Global Cell & Gene Therapy Clinical Trials Market Overview, By Indication

9.1.1. Global Cell & Gene Therapy Clinical Trials Market Revenue Share, By Indication, 2022 Vs 2030 (in %)

9.2. Oncology

9.2.1. Global Cell & Gene Therapy Clinical Trials Market, By Oncology, By Region, 2017-2030 (US$ Mn)

9.2.2. Market Dynamics for Oncology

9.2.2.1. Drivers

9.2.2.2. Restraints

9.2.2.3. Opportunities

9.2.2.4. Trends

9.3. Genetic Disorders

9.3.1. Global Cell & Gene Therapy Clinical Trials Market, By Genetic Disorders, By Region, 2017-2030 (US$ Mn)

9.3.2. Market Dynamics for Genetic Disorders

9.3.2.1. Drivers

9.3.2.2. Restraints

9.3.2.3. Opportunities

9.3.2.4. Trends

9.4. Genetic Disorders

9.4.1. Global Cell & Gene Therapy Clinical Trials Market, By Genetic Disorders, By Region, 2017-2030 (US$ Mn)

9.4.2. Market Dynamics for Genetic Disorders

9.4.2.1. Drivers

9.4.2.2. Restraints

9.4.2.3. Opportunities

9.4.2.4. Trends

9.5. Cardiovascular Disorders

9.5.1. Global Cell & Gene Therapy Clinical Trials Market, By Cardiovascular Disorders, By Region, 2017-2030 (US$ Mn)

9.5.2. Market Dynamics for Cardiovascular Disorders

9.5.2.1. Drivers

9.5.2.2. Restraints

9.5.2.3. Opportunities

9.5.2.4. Trends

9.6. Neurological Disorders

9.6.1. Global Cell & Gene Therapy Clinical Trials Market, By Neurological Disorders, By Region, 2017-2030 (US$ Mn)

9.6.2. Market Dynamics for Neurological Disorders

9.6.2.1. Drivers

9.6.2.2. Restraints

9.6.2.3. Opportunities

9.6.2.4. Trends

9.7. Infectious Diseases

9.7.1. Global Cell & Gene Therapy Clinical Trials Market, By Infectious Diseases, By Region, 2017-2030 (US$ Mn)

9.7.2. Market Dynamics for Infectious Diseases

9.7.2.1. Drivers

9.7.2.2. Restraints

9.7.2.3. Opportunities

9.7.2.4. Trends

9.8. Others

9.8.1. Global Cell & Gene Therapy Clinical Trials Market, By Others, By Region, 2017-2030 (US$ Mn)

9.8.2. Market Dynamics for Others

9.8.2.1. Drivers

9.8.2.2. Restraints

9.8.2.3. Opportunities

9.8.2.4. Trends

 

10. Global Cell & Gene Therapy Clinical Trials Market, By Phase of Clinical Trials

10.1. Global Cell & Gene Therapy Clinical Trials Market Overview, By Phase of Clinical Trials

10.1.1. Global Cell & Gene Therapy Clinical Trials Market Revenue Share, By Phase of Clinical Trials, 2022 Vs 2030 (in %)

10.2. Phase I

10.2.1. Global Cell & Gene Therapy Clinical Trials Market, By Phase I, By Region, 2017-2030 (US$ Mn)

10.2.2. Market Dynamics for Phase I

10.2.2.1. Drivers

10.2.2.2. Restraints

10.2.2.3. Opportunities

10.2.2.4. Trends

10.3. Phase II

10.3.1. Global Cell & Gene Therapy Clinical Trials Market, By Phase II, By Region, 2017-2030 (US$ Mn)

10.3.2. Market Dynamics for Phase II

10.3.2.1. Drivers

10.3.2.2. Restraints

10.3.2.3. Opportunities

10.3.2.4. Trends

10.4. Phase III

10.4.1. Global Cell & Gene Therapy Clinical Trials Market, By Phase III, By Region, 2017-2030 (US$ Mn)

10.4.2. Market Dynamics for Phase III

10.4.2.1. Drivers

10.4.2.2. Restraints

10.4.2.3. Opportunities

10.4.2.4. Trends

 

11. Global Cell & Gene Therapy Clinical Trials Market, By Trial Design

11.1. Global Cell & Gene Therapy Clinical Trials Market Overview, by Trial Design

11.1.1. Global Cell & Gene Therapy Clinical Trials Market Revenue Share, By Trial Design, 2022 Vs 2030 (in %)

11.2. Randomized Controlled Trials (RCTs)

11.2.1. Global Cell & Gene Therapy Clinical Trials Market, By Randomized Controlled Trials (RCTs), By Region, 2017-2030 (US$ Mn)

11.2.2. Market Dynamics for Randomized Controlled Trials (RCTs)

11.2.2.1. Drivers

11.2.2.2. Restraints

11.2.2.3. Opportunities

11.2.2.4. Trends

11.3. Non-Randomized Trials

11.3.1. Global Cell & Gene Therapy Clinical Trials Market, By Non-Randomized Trials, By Region, 2017-2030 (US$ Mn)

11.3.2. Market Dynamics for Non-Randomized Trials

11.3.2.1. Drivers

11.3.2.2. Restraints

11.3.2.3. Opportunities

11.3.2.4. Trends

 

12. Global Cell & Gene Therapy Clinical Trials Market, By Patient Age

12.1. Global Cell & Gene Therapy Clinical Trials Market Overview, by Patient Age

12.1.1. Global Cell & Gene Therapy Clinical Trials Market Revenue Share, By Patient Age, 2022 Vs 2030 (in %)

12.2. Pediatric Patients

12.2.1. Global Cell & Gene Therapy Clinical Trials Market, By Pediatric Patients, By Region, 2017-2030 (US$ Mn)

12.2.2. Market Dynamics for Pediatric Patients

12.2.2.1. Drivers

12.2.2.2. Restraints

12.2.2.3. Opportunities

12.2.2.4. Trends

12.3. Adult Patients

12.3.1. Global Cell & Gene Therapy Clinical Trials Market, By Adult Patients, By Region, 2017-2030 (US$ Mn)

12.3.2. Market Dynamics for Adult Patients

12.3.2.1. Drivers

12.3.2.2. Restraints

12.3.2.3. Opportunities

12.3.2.4. Trends

 

13. Global Cell & Gene Therapy Clinical Trials Market, By Region

13.1. Global Cell & Gene Therapy Clinical Trials Market Overview, by Region

13.1.1. Global Cell & Gene Therapy Clinical Trials Market, By Region, 2022 vs 2030 (in%)

13.2. Therapy Type

13.2.1. Global Cell & Gene Therapy Clinical Trials Market, By Therapy Type, 2017-2030 (US$ Mn)

13.3. Indication

13.3.1. Global Cell & Gene Therapy Clinical Trials Market, By Indication, 2017-2030 (US$ Mn)

13.4. Phase of Clinical Trials

13.4.1. Global Cell & Gene Therapy Clinical Trials Market, By Phase of Clinical Trials, 2017-2030 (US$ Mn)

13.5. Trial Design

13.5.1. Global Cell & Gene Therapy Clinical Trials Market, By Trial Design, 2017-2030 (US$ Mn)

13.6. Patient Age

13.6.1. Global Cell & Gene Therapy Clinical Trials Market, By Patient Age, 2017-2030 (US$ Mn)

 

14. North America Cell & Gene Therapy Clinical Trials Market Analysis

14.1. Overview

14.1.1. Market Dynamics for North America

14.1.1.1. Drivers

14.1.1.2. Restraints

14.1.1.3. Opportunities

14.1.1.4. Trends

14.2. North America Cell & Gene Therapy Clinical Trials Market, By Therapy Type, 2017-2030(US$ Mn)

14.2.1. Overview

14.2.2. SRC Analysis

14.3. North America Cell & Gene Therapy Clinical Trials Market, By Indication, 2017-2030(US$ Mn)

14.3.1. Overview

14.3.2. SRC Analysis

14.4. North America Cell & Gene Therapy Clinical Trials Market, By Phase of Clinical Trials, 2017-2030(US$ Mn)

14.4.1. Overview

14.4.2. SRC Analysis

14.5. North America Cell & Gene Therapy Clinical Trials Market, By Trial Design, 2017-2030(US$ Mn)

14.5.1. Overview

14.5.2. SRC Analysis

14.6. North America Cell & Gene Therapy Clinical Trials Market, by Patient Age, 2017-2030(US$ Mn)

14.6.1. Overview

14.6.2. SRC Analysis

14.7. North America Cell & Gene Therapy Clinical Trials Market, by Country, 2017-2030(US$ Mn)

14.7.1. North America Cell & Gene Therapy Clinical Trials Market, by Country, 2022 Vs 2030 (in%)

14.7.2. U.S.

14.7.3. Canada

14.7.4. Mexico

 

15. Europe Cell & Gene Therapy Clinical Trials Market Analysis

15.1. Overview

15.1.1. Market Dynamics for North America

15.1.1.1. Drivers

15.1.1.2. Restraints

15.1.1.3. Opportunities

15.1.1.4. Trends

15.2. EuropeCell & Gene Therapy Clinical Trials Market, By Therapy Type, 2017-2030(US$ Mn)

15.2.1. Overview

15.2.2. SRC Analysis

15.3. EuropeCell & Gene Therapy Clinical Trials Market, By Indication, 2017-2030(US$ Mn)

15.3.1. Overview

15.3.2. SRC Analysis

15.4. EuropeCell & Gene Therapy Clinical Trials Market, By Phase of Clinical Trials, 2017-2030(US$ Mn)

15.4.1. Overview

15.4.2. SRC Analysis

15.5. EuropeCell & Gene Therapy Clinical Trials Market, By Trial Design, 2017-2030(US$ Mn)

15.5.1. Overview

15.5.2. SRC Analysis

15.6. EuropeCell & Gene Therapy Clinical Trials Market, by Patient Age, 2017-2030(US$ Mn)

15.6.1. Overview

15.6.2. SRC Analysis

15.7. EuropeCell & Gene Therapy Clinical Trials Market, by Country, 2017-2030 (US$ Mn)

15.7.1. EuropeCell & Gene Therapy Clinical Trials Market, by Country, 2022 Vs 2030 (in%)

15.7.2. UK

15.7.3. France

15.7.4. Germany

15.7.5. Italy

15.7.6. Spain

15.7.7. Benelux

15.7.8. Russia

15.7.9. Rest of Europe

 

16. Asia Pacific Cell & Gene Therapy Clinical Trials Market Analysis

16.1. Overview

16.1.1. Market Dynamics for North America

16.1.1.1. Drivers

16.1.1.2. Restraints

16.1.1.3. Opportunities

16.1.1.4. Trends

16.2. Asia PacificCell & Gene Therapy Clinical Trials Market, By Therapy Type, 2017-2030(US$ Mn)

16.2.1. Overview

16.2.2. SRC Analysis

16.3. Asia PacificCell & Gene Therapy Clinical Trials Market, By Indication, 2017-2030(US$ Mn)

16.3.1. Overview

16.3.2. SRC Analysis

16.4. Asia PacificCell & Gene Therapy Clinical Trials Market, By Phase of Clinical Trials, 2017-2030(US$ Mn)

16.4.1. Overview

16.4.2. SRC Analysis

16.5. Asia PacificCell & Gene Therapy Clinical Trials Market, By Trial Design, 2017-2030(US$ Mn)

16.5.1. Overview

16.5.2. SRC Analysis

16.6. Asia PacificCell & Gene Therapy Clinical Trials Market, by Patient Age, 2017-2030(US$ Mn)

16.6.1. Overview

16.6.2. SRC Analysis

16.7. Asia Pacific Cell & Gene Therapy Clinical Trials Market, by Country, 2017-2030 (US$ Mn)

16.7.1. Asia Pacific Cell & Gene Therapy Clinical Trials Market, by Country, 2022 Vs 2030 (in%)

16.7.2. China

16.7.3. Japan

16.7.4. India

16.7.5. South Korea

16.7.6. South East Asia

16.7.7. Rest of Asia Pacific

 

17. Latin America Cell & Gene Therapy Clinical Trials Market Analysis

17.1. Overview

17.1.1. Market Dynamics for North America

17.1.1.1. Drivers

17.1.1.2. Restraints

17.1.1.3. Opportunities

17.1.1.4. Trends

17.2. Latin America Cell & Gene Therapy Clinical Trials Market, By Therapy Type, 2017-2030(US$ Mn)

17.2.1. Overview

17.2.2. SRC Analysis

17.3. Latin AmericaCell & Gene Therapy Clinical Trials Market, By Indication, 2017-2030(US$ Mn)

17.3.1. Overview

17.3.2. SRC Analysis

17.4. Latin AmericaCell & Gene Therapy Clinical Trials Market, By Phase of Clinical Trials, 2017-2030(US$ Mn)

17.4.1. Overview

17.4.2. SRC Analysis

17.5. Latin AmericaCell & Gene Therapy Clinical Trials Market, By Trial Design, 2017-2030(US$ Mn)

17.5.1. Overview

17.5.2. SRC Analysis

17.6. Latin AmericaCell & Gene Therapy Clinical Trials Market, by Patient Age, 2017-2030(US$ Mn)

17.6.1. Overview

17.6.2. SRC Analysis

17.7. Latin AmericaCell & Gene Therapy Clinical Trials Market, by Country, 2017-2030 (US$ Mn)

17.7.1. Latin AmericaCell & Gene Therapy Clinical Trials Market, by Country, 2022 Vs 2030 (in%)

17.7.2. Brazil

17.7.3. Argentina

17.7.4. Rest of Latin America

 

18. Middle East Cell & Gene Therapy Clinical Trials Market Analysis

18.1. Overview

18.1.1. Market Dynamics for North America

18.1.1.1. Drivers

18.1.1.2. Restraints

18.1.1.3. Opportunities

18.1.1.4. Trends

18.2. Middle East Cell & Gene Therapy Clinical Trials Market, By Therapy Type, 2017-2030(US$ Mn)

18.2.1. Overview

18.2.2. SRC Analysis

18.3. Middle East Cell & Gene Therapy Clinical Trials Market, By Indication, 2017-2030(US$ Mn)

18.3.1. Overview

18.3.2. SRC Analysis

18.4. Middle EastCell & Gene Therapy Clinical Trials Market, By Phase of Clinical Trials, 2017-2030(US$ Mn)

18.4.1. Overview

18.4.2. SRC Analysis

18.5. Middle East Cell & Gene Therapy Clinical Trials Market, By Trial Design, 2017-2030(US$ Mn)

18.5.1. Overview

18.5.2. SRC Analysis

18.6. Middle East Cell & Gene Therapy Clinical Trials Market, by Patient Age, 2017-2030(US$ Mn)

18.6.1. Overview

18.6.2. SRC Analysis

18.7. Middle East Cell & Gene Therapy Clinical Trials Market, by Country, 2017-2030 (US$ Mn)

18.7.1. Middle EastCell & Gene Therapy Clinical Trials Market, by Country, 2022 Vs 2030 (in%)

18.7.2. UAE

18.7.3. Saudi Arabia

18.7.4. Rest of Middle East

 

19. Africa Cell & Gene Therapy Clinical Trials Market Analysis

19.1. Overview

19.1.1. Market Dynamics for North America

19.1.1.1. Drivers

19.1.1.2. Restraints

19.1.1.3. Opportunities

19.1.1.4. Trends

19.2. Africa Cell & Gene Therapy Clinical Trials Market, By Therapy Type, 2017-2030(US$ Mn)

19.2.1. Overview

19.2.2. SRC Analysis

19.3. Africa Cell & Gene Therapy Clinical Trials Market, By Indication, 2017-2030(US$ Mn)

19.3.1. Overview

19.3.2. SRC Analysis

19.4. Africa Cell & Gene Therapy Clinical Trials Market, By Phase of Clinical Trials, 2017-2030(US$ Mn)

19.4.1. Overview

19.4.2. SRC Analysis

19.5. Africa Cell & Gene Therapy Clinical Trials Market, By Trial Design, 2017-2030(US$ Mn)

19.5.1. Overview

19.5.2. SRC Analysis

19.6. Africa Cell & Gene Therapy Clinical Trials Market, by Patient Age, 2017-2030(US$ Mn)

19.6.1. Overview

19.6.2. SRC Analysis

19.7. Africa Cell & Gene Therapy Clinical Trials Market, by Country, 2017-2030 (US$ Mn)

19.7.1. Middle EastCell & Gene Therapy Clinical Trials Market, by Country, 2022 Vs 2030 (in%)

19.7.2. South Africa

19.7.3. Egypt

19.7.4. Rest of Africa

 

20. Company Profiles

20.1. IQVIA

20.1.1. Company Overview

20.1.2. Products/Services Portfolio

20.1.3. Geographical Presence

20.1.4. SWOT Analysis

20.1.5. Financial Summary

20.1.5.1. Market Revenue and Net Profit (2019-2022)

20.1.5.2. Business Segment Revenue Analysis

20.1.5.3. Geographical Revenue Analysis

20.2. ICON Plc

20.3. Laboratory Corporation of America Holdings

20.4. Charles River Laboratories International, Inc.

20.5. PAREXEL International Corp.

20.6. Syneos Health

20.7. Medpace, Holdings, Inc.

20.8. PPD Inc.

20.9. Novotech

20.10. Veristat, LLC

 

21. Research Methodology

21.1. Research Methodology

21.2. Phase I – Secondary Research

21.3. Phase II – Data Modelling

21.3.1. Company Share Analysis Model

21.3.2. Revenue Based Modelling

21.4. Phase III – Primary Research

21.5. Research Limitations

21.5.1. Assumptions

List of Figures

FIG. 1 Global Cell & Gene Therapy Clinical Trials Market: Research Methodology

FIG. 2 Market Size Estimation – Top Down & Bottom up Approach

FIG. 3 Global Cell & Gene Therapy Clinical Trials Market Segmentation

FIG. 4 Global Cell & Gene Therapy Clinical Trials Market, By Therapy Type, 2022 (US$ Mn)

FIG. 5 Global Cell & Gene Therapy Clinical Trials Market, By Indication, 2022 (US$ Mn)

FIG. 6 Global Cell & Gene Therapy Clinical Trials Market, By Phase of Clinical Trials, 2022 (US$ Mn)

FIG. 7 Global Cell & Gene Therapy Clinical Trials Market, by Trial Design, 2022 (US$ Mn)

FIG. 8 Global Cell & Gene Therapy Clinical Trials Market, by Patient Age, 2022 (US$ Mn)

FIG. 9 Global Cell & Gene Therapy Clinical Trials Market, by Geography, 2022 (US$ Mn)

FIG. 10 Attractive Investment Proposition, By Therapy Type, 2022

FIG. 11 Attractive Investment Proposition, By Indication, 2022

FIG. 12 Attractive Investment Proposition, By Phase of Clinical Trials, 2022

FIG. 13 Attractive Investment Proposition, By Trial Design, 2022

FIG. 14 Attractive Investment Proposition, by Patient Age, 2022

FIG. 15 Attractive Investment Proposition, by Geography, 2022

FIG. 16 Global Market Share Analysis of Key Cell & Gene Therapy Clinical Trials Market Manufacturers, 2022

FIG. 17 Global Market Positioning of Key Cell & Gene Therapy Clinical Trials Market Manufacturers, 2022

FIG. 18 Global Cell & Gene Therapy Clinical Trials Market Value Contribution, By Therapy Type, 2022 & 2030 (Value %)

FIG. 19 Global Cell & Gene Therapy Clinical Trials Market, by CELL THERAPY, Value, 2017-2030 (US$ Mn)

FIG. 20 Global Cell & Gene Therapy Clinical Trials Market, by GENE THERAPY, Value, 2017-2030 (US$ Mn)

FIG. 21 Global Cell & Gene Therapy Clinical Trials Market Value Contribution, By Indication, 2022 & 2030 (Value %)

FIG. 22 Global Cell & Gene Therapy Clinical Trials Market, by Oncology, Value, 2017-2030 (US$ Mn)

FIG. 23 Global Cell & Gene Therapy Clinical Trials Market, by Genetic Disorders, Value, 2017-2030 (US$ Mn)

FIG. 24 Global Cell & Gene Therapy Clinical Trials Market, by Cardiovascular Disorders, Value, 2017-2030 (US$ Mn)

FIG. 25 Global Cell & Gene Therapy Clinical Trials Market, by Neurological Disorders, Value, 2017-2030 (US$ Mn)

FIG. 26 Global Cell & Gene Therapy Clinical Trials Market, by Infectious Diseases, Value, 2017-2030 (US$ Mn)

FIG. 27 Global Cell & Gene Therapy Clinical Trials Market Value Contribution, By Phase of Clinical Trials, 2022 & 2030 (Value %)

FIG. 28 Global Cell & Gene Therapy Clinical Trials Market, by Phase I, Value, 2017-2030 (US$ Mn)

FIG. 29 Global Cell & Gene Therapy Clinical Trials Market, by Phase II, Value, 2017-2030 (US$ Mn)

FIG. 30 Global Cell & Gene Therapy Clinical Trials Market, by Phase III, Value, 2017-2030 (US$ Mn)

FIG. 31 Global Cell & Gene Therapy Clinical Trials Market Value Contribution, By Trial Design, 2022 & 2030 (Value %)

FIG. 32 Global Cell & Gene Therapy Clinical Trials Market, by Randomized Controlled Trials (RCTs), Value, 2017-2030 (US$ Mn)

FIG. 33 Global Cell & Gene Therapy Clinical Trials Market, by Non-Randomized Trials, Value, 2017-2030 (US$ Mn)

FIG. 34 Global Cell & Gene Therapy Clinical Trials Market Value Contribution, By Patient Age, 2022 & 2030 (Value %)

FIG. 35 Global Cell & Gene Therapy Clinical Trials Market, by Pediatric Patients, Value, 2017-2030 (US$ Mn)

FIG. 36 Global Cell & Gene Therapy Clinical Trials Market, by Adult Patients, Value, 2017-2030 (US$ Mn)

FIG. 37 North America Cell & Gene Therapy Clinical Trials Market, 2017-2030 (US$ Mn)

FIG. 38 U.S. Cell & Gene Therapy Clinical Trials Market, 2017-2030 (US$ Mn)

FIG. 39 Canada Cell & Gene Therapy Clinical Trials Market, 2017-2030 (US$ Mn)

FIG. 40 MexicoCell & Gene Therapy Clinical Trials Market, 2017-2030 (US$ Mn)

FIG. 41 Europe Cell & Gene Therapy Clinical Trials Market, 2017-2030 (US$ Mn)

FIG. 42 Germany Cell & Gene Therapy Clinical Trials Market, 2017-2030 (US$ Mn)

FIG. 43 France Cell & Gene Therapy Clinical Trials Market, 2017-2030 (US$ Mn)

FIG. 44 U.K. Cell & Gene Therapy Clinical Trials Market, 2017-2030 (US$ Mn)

FIG. 45 Italy Cell & Gene Therapy Clinical Trials Market, 2017-2030 (US$ Mn)

FIG. 46 Spain Cell & Gene Therapy Clinical Trials Market, 2017-2030 (US$ Mn)

FIG. 47 BeneluxCell & Gene Therapy Clinical Trials Market, 2017-2030 (US$ Mn)

FIG. 48 RussiaCell & Gene Therapy Clinical Trials Market, 2017-2030 (US$ Mn)

FIG. 49 Rest of Europe Cell & Gene Therapy Clinical Trials Market, 2017-2030 (US$ Mn)

FIG. 50 Asia Pacific Cell & Gene Therapy Clinical Trials Market, 2017-2030 (US$ Mn)

FIG. 51 China Cell & Gene Therapy Clinical Trials Market, 2017-2030 (US$ Mn)

FIG. 52 Japan Cell & Gene Therapy Clinical Trials Market, 2017-2030 (US$ Mn)

FIG. 53 India Cell & Gene Therapy Clinical Trials Market, 2017-2030 (US$ Mn)

FIG. 54 South Korea Cell & Gene Therapy Clinical Trials Market, 2017-2030 (US$ Mn)

FIG. 55 South-East Asia Cell & Gene Therapy Clinical Trials Market, 2017-2030 (US$ Mn)

FIG. 56 Rest of Asia Pacific Cell & Gene Therapy Clinical Trials Market, 2017-2030 (US$ Mn)

FIG. 57 Latin America Cell & Gene Therapy Clinical Trials Market, 2017-2030 (US$ Mn)

FIG. 58 Brazil Cell & Gene Therapy Clinical Trials Market, 2017-2030 (US$ Mn)

FIG. 59 ArgentinaCell & Gene Therapy Clinical Trials Market, 2017-2030 (US$ Mn)

FIG. 60 Rest of Latin America Cell & Gene Therapy Clinical Trials Market, 2017-2030 (US$ Mn)

FIG. 61 Middle East Cell & Gene Therapy Clinical Trials Market, 2017-2030 (US$ Mn)

FIG. 62 UAECell & Gene Therapy Clinical Trials Market, 2017-2030 (US$ Mn)

FIG. 63 Saudi ArabiaCell & Gene Therapy Clinical Trials Market, 2017-2030 (US$ Mn)

FIG. 64 Rest of Middle East Cell & Gene Therapy Clinical Trials Market, 2017-2030 (US$ Mn)

FIG. 65 AfricaCell & Gene Therapy Clinical Trials Market, 2017-2030 (US$ Mn)

FIG. 66 South Africa Cell & Gene Therapy Clinical Trials Market, 2017-2030 (US$ Mn)

FIG. 67 EgyptCell & Gene Therapy Clinical Trials Market, 2017-2030 (US$ Mn)

FIG. 68 Rest of Africa Cell & Gene Therapy Clinical Trials Market, 2017-2030 (US$ Mn)

 

List of Tables

TABLE 1 Market Snapshot: Global Cell & Gene Therapy Clinical Trials Market

TABLE 2 Global Cell & Gene Therapy Clinical Trials Market: Market Drivers Impact Analysis

TABLE 3 Global Cell & Gene Therapy Clinical Trials Market: Market Restraints Impact Analysis

TABLE 4 Global Cell & Gene Therapy Clinical Trials Market, by Competitive Benchmarking, 2022

TABLE 5 Global Cell & Gene Therapy Clinical Trials Market, by Geographical Presence Analysis, 2022

TABLE 6 Global Cell & Gene Therapy Clinical Trials Market, by Key Strategies Analysis, 2022

TABLE 7 Global Cell & Gene Therapy Clinical Trials Market, by CELL THERAPY, By Region, 2017-2022 (US$ Mn)

TABLE 8 Global Cell & Gene Therapy Clinical Trials Market, by CELL THERAPY, By Region, 2023-2030 (US$ Mn)

TABLE 9 Global Cell & Gene Therapy Clinical Trials Market, by GENE THERAPY, By Region, 2017-2022 (US$ Mn)

TABLE 10 Global Cell & Gene Therapy Clinical Trials Market, by GENE THERAPY, By Region, 2023-2030 (US$ Mn)

TABLE 11 Global Cell & Gene Therapy Clinical Trials Market, by Oncology, By Region, 2017-2022 (US$ Mn)

TABLE 12 Global Cell & Gene Therapy Clinical Trials Market, by Oncology, By Region, 2023-2030 (US$ Mn)

TABLE 13 Global Cell & Gene Therapy Clinical Trials Market, by Genetic Disorders, By Region, 2017-2022 (US$ Mn)

TABLE 14 Global Cell & Gene Therapy Clinical Trials Market, by Genetic Disorders, By Region, 2023-2030 (US$ Mn)

TABLE 15 Global Cell & Gene Therapy Clinical Trials Market, by Cardiovascular Disorders, By Region, 2017-2022 (US$ Mn)

TABLE 16 Global Cell & Gene Therapy Clinical Trials Market, by Cardiovascular Disorders, By Region, 2023-2030 (US$ Mn)

TABLE 17 Global Cell & Gene Therapy Clinical Trials Market, by Neurological Disorders, By Region, 2017-2022 (US$ Mn)

TABLE 18 Global Cell & Gene Therapy Clinical Trials Market, by Neurological Disorders, By Region, 2023-2030 (US$ Mn)

TABLE 19 Global Cell & Gene Therapy Clinical Trials Market, by Infectious Diseases, By Region, 2017-2022 (US$ Mn)

TABLE 20 Global Cell & Gene Therapy Clinical Trials Market, by Infectious Diseases, By Region, 2023-2030 (US$ Mn)

TABLE 21 Global Cell & Gene Therapy Clinical Trials Market, by Phase I, By Region, 2017-2022 (US$ Mn)

TABLE 22 Global Cell & Gene Therapy Clinical Trials Market, by Phase I, By Region, 2023-2030 (US$ Mn)

TABLE 23 Global Cell & Gene Therapy Clinical Trials Market, by Phase II, By Region, 2017-2022 (US$ Mn)

TABLE 24 Global Cell & Gene Therapy Clinical Trials Market, by Phase II, By Region, 2023-2030 (US$ Mn)

TABLE 25 Global Cell & Gene Therapy Clinical Trials Market, by Phase III, By Region, 2017-2022 (US$ Mn)

TABLE 26 Global Cell & Gene Therapy Clinical Trials Market, by Phase III, By Region, 2023-2030 (US$ Mn)

TABLE 27 Global Cell & Gene Therapy Clinical Trials Market, by Randomized Controlled Trials (RCTs), By Region, 2017-2022 (US$ Mn)

TABLE 28 Global Cell & Gene Therapy Clinical Trials Market, by Randomized Controlled Trials (RCTs), By Region, 2023-2030 (US$ Mn)

TABLE 29 Global Cell & Gene Therapy Clinical Trials Market, by Non-Randomized Trials, By Region, 2017-2022 (US$ Mn)

TABLE 30 Global Cell & Gene Therapy Clinical Trials Market, by Non-Randomized Trials, By Region, 2023-2030 (US$ Mn)

TABLE 31 Global Cell & Gene Therapy Clinical Trials Market, by Pediatric Patients, By Region, 2017-2022 (US$ Mn)

TABLE 32 Global Cell & Gene Therapy Clinical Trials Market, by Pediatric Patients, By Region, 2023-2030 (US$ Mn)

TABLE 33 Global Cell & Gene Therapy Clinical Trials Market, By Therapy Type, 2017-2022 (US$ Mn)

TABLE 34 Global Cell & Gene Therapy Clinical Trials Market, By Therapy Type, 2023-2030 (US$ Mn)

TABLE 35 Global Cell & Gene Therapy Clinical Trials Market, By Indication, 2017-2022 (US$ Mn)

TABLE 36 Global Cell & Gene Therapy Clinical Trials Market, By Indication, 2023-2030 (US$ Mn)

TABLE 37 Global Cell & Gene Therapy Clinical Trials Market, By Phase of Clinical Trials, 2017-2022 (US$ Mn)

TABLE 38 Global Cell & Gene Therapy Clinical Trials Market, By Phase of Clinical Trials, 2023-2030 (US$ Mn)

TABLE 39 Global Cell & Gene Therapy Clinical Trials Market, By Trial Design, By Region, 2017-2022 (US$ Mn)

TABLE 40 Global Cell & Gene Therapy Clinical Trials Market, By Trial Design, By Region, 2023-2030 (US$ Mn)

TABLE 41 Global Cell & Gene Therapy Clinical Trials Market, by Patient Age, 2017-2022 (US$ Mn)

TABLE 42 Global Cell & Gene Therapy Clinical Trials Market, by Region, 2017-2022 (US$ Mn)

TABLE 43 Global Cell & Gene Therapy Clinical Trials Market, by Region, 2023-2030 (US$ Mn)

TABLE 44 North America Cell & Gene Therapy Clinical Trials Market, By Therapy Type, 2017-2022 (US$ Mn)

TABLE 45 North America Cell & Gene Therapy Clinical Trials Market, By Therapy Type, 2023-2030 (US$ Mn)

TABLE 46 North America Cell & Gene Therapy Clinical Trials Market, By Indication, 2017-2022 (US$ Mn)

TABLE 47 North America Cell & Gene Therapy Clinical Trials Market, By Indication, 2023-2030 (US$ Mn)

TABLE 48 North America Cell & Gene Therapy Clinical Trials Market, By Phase of Clinical Trials, 2017-2022 (US$ Mn)

TABLE 49 North America Cell & Gene Therapy Clinical Trials Market, By Phase of Clinical Trials, 2023-2030 (US$ Mn)

TABLE 50 North AmericaCell & Gene Therapy Clinical Trials Market, By Trial Design, By Region, 2017-2022 (US$ Mn)

TABLE 51 North AmericaCell & Gene Therapy Clinical Trials Market, By Trial Design, By Region, 2023-2030 (US$ Mn)

TABLE 52 North AmericaCell & Gene Therapy Clinical Trials Market, by Patient Age, 2017-2022 (US$ Mn)

TABLE 53 North AmericaCell & Gene Therapy Clinical Trials Market, by Patient Age, 2023-2030 (US$ Mn)

TABLE 54 North America Cell & Gene Therapy Clinical Trials Market, by Country, 2017-2022 (US$ Mn)

TABLE 55 North America Cell & Gene Therapy Clinical Trials Market, by Country, 2023-2030 (US$ Mn)

TABLE 56 United States Cell & Gene Therapy Clinical Trials Market, By Therapy Type, 2017-2022 (US$ Mn)

TABLE 57 United States Cell & Gene Therapy Clinical Trials Market, By Therapy Type, 2023-2030 (US$ Mn)

TABLE 58 United States Cell & Gene Therapy Clinical Trials Market, By Indication, 2017-2022 (US$ Mn)

TABLE 59 United States Cell & Gene Therapy Clinical Trials Market, By Indication, 2023-2030 (US$ Mn)

TABLE 60 United States Cell & Gene Therapy Clinical Trials Market, By Phase of Clinical Trials, 2017-2022 (US$ Mn)

TABLE 61 United States Cell & Gene Therapy Clinical Trials Market, By Phase of Clinical Trials, 2023-2030 (US$ Mn)

TABLE 62 United StatesCell & Gene Therapy Clinical Trials Market, By Trial Design, By Region, 2017-2022 (US$ Mn)

TABLE 63 United StatesCell & Gene Therapy Clinical Trials Market, By Trial Design, By Region, 2023-2030 (US$ Mn)

TABLE 64 United StatesCell & Gene Therapy Clinical Trials Market, by Patient Age, 2017-2022 (US$ Mn)

TABLE 65 United StatesCell & Gene Therapy Clinical Trials Market, by Patient Age, 2023-2030 (US$ Mn)

TABLE 66 Canada Cell & Gene Therapy Clinical Trials Market, By Therapy Type, 2017-2022 (US$ Mn)

TABLE 67 Canada Cell & Gene Therapy Clinical Trials Market, By Therapy Type, 2023-2030 (US$ Mn)

TABLE 68 Canada Cell & Gene Therapy Clinical Trials Market, By Indication, 2017-2022 (US$ Mn)

TABLE 69 Canada Cell & Gene Therapy Clinical Trials Market, By Indication, 2023-2030 (US$ Mn)

TABLE 70 Canada Cell & Gene Therapy Clinical Trials Market, By Phase of Clinical Trials, 2017-2022 (US$ Mn)

TABLE 71 Canada Cell & Gene Therapy Clinical Trials Market, By Phase of Clinical Trials, 2023-2030 (US$ Mn)

TABLE 72 CanadaCell & Gene Therapy Clinical Trials Market, By Trial Design, By Region, 2017-2022 (US$ Mn)

TABLE 73 CanadaCell & Gene Therapy Clinical Trials Market, By Trial Design, By Region, 2023-2030 (US$ Mn)

TABLE 74 CanadaCell & Gene Therapy Clinical Trials Market, by Patient Age, 2017-2022 (US$ Mn)

TABLE 75 CanadaCell & Gene Therapy Clinical Trials Market, by Patient Age, 2023-2030 (US$ Mn)

TABLE 76 Mexico Cell & Gene Therapy Clinical Trials Market, By Therapy Type, 2017-2022 (US$ Mn)

TABLE 77 Mexico Cell & Gene Therapy Clinical Trials Market, By Therapy Type, 2023-2030 (US$ Mn)

TABLE 78 Mexico Cell & Gene Therapy Clinical Trials Market, By Indication, 2017-2022 (US$ Mn)

TABLE 79 Mexico Cell & Gene Therapy Clinical Trials Market, By Indication, 2023-2030 (US$ Mn)

TABLE 80 Mexico Cell & Gene Therapy Clinical Trials Market, By Phase of Clinical Trials, 2017-2022 (US$ Mn)

TABLE 81 Mexico Cell & Gene Therapy Clinical Trials Market, By Phase of Clinical Trials, 2023-2030 (US$ Mn)

TABLE 82 MexicoCell & Gene Therapy Clinical Trials Market, By Trial Design, By Region, 2017-2022 (US$ Mn)

TABLE 83 MexicoCell & Gene Therapy Clinical Trials Market, By Trial Design, By Region, 2023-2030 (US$ Mn)

TABLE 84 MexicoCell & Gene Therapy Clinical Trials Market, by Patient Age, 2017-2022 (US$ Mn)

TABLE 85 MexicoCell & Gene Therapy Clinical Trials Market, by Patient Age, 2023-2030 (US$ Mn)

TABLE 86 Europe Cell & Gene Therapy Clinical Trials Market, By Therapy Type, 2017-2022 (US$ Mn)

TABLE 87 Europe Cell & Gene Therapy Clinical Trials Market, By Therapy Type, 2023-2030 (US$ Mn)

TABLE 88 Europe Cell & Gene Therapy Clinical Trials Market, By Indication, 2017-2022 (US$ Mn)

TABLE 89 Europe Cell & Gene Therapy Clinical Trials Market, By Indication, 2023-2030 (US$ Mn)

TABLE 90 Europe Cell & Gene Therapy Clinical Trials Market, By Phase of Clinical Trials, 2017-2022 (US$ Mn)

TABLE 91 Europe Cell & Gene Therapy Clinical Trials Market, By Phase of Clinical Trials, 2023-2030 (US$ Mn)

TABLE 92 EuropeCell & Gene Therapy Clinical Trials Market, By Trial Design, By Region, 2017-2022 (US$ Mn)

TABLE 93 EuropeCell & Gene Therapy Clinical Trials Market, By Trial Design, By Region, 2023-2030 (US$ Mn)

TABLE 94 EuropeCell & Gene Therapy Clinical Trials Market, by Patient Age, 2017-2022 (US$ Mn)

TABLE 95 EuropeCell & Gene Therapy Clinical Trials Market, by Patient Age, 2023-2030 (US$ Mn)

TABLE 96 Europe Cell & Gene Therapy Clinical Trials Market, by Country, 2017-2022 (US$ Mn)

TABLE 97 Europe Cell & Gene Therapy Clinical Trials Market, by Country, 2023-2030 (US$ Mn)

TABLE 98 Germany Cell & Gene Therapy Clinical Trials Market, By Therapy Type, 2017-2022 (US$ Mn)

TABLE 99 Germany Cell & Gene Therapy Clinical Trials Market, By Therapy Type, 2023-2030 (US$ Mn)

TABLE 100 Germany Cell & Gene Therapy Clinical Trials Market, By Indication, 2017-2022 (US$ Mn)

TABLE 101 Germany Cell & Gene Therapy Clinical Trials Market, By Indication, 2023-2030 (US$ Mn)

TABLE 102 Germany Cell & Gene Therapy Clinical Trials Market, By Phase of Clinical Trials, 2017-2022 (US$ Mn)

TABLE 103 Germany Cell & Gene Therapy Clinical Trials Market, By Phase of Clinical Trials, 2023-2030 (US$ Mn)

TABLE 104 GermanyCell & Gene Therapy Clinical Trials Market, By Trial Design, By Region, 2017-2022 (US$ Mn)

TABLE 105 GermanyCell & Gene Therapy Clinical Trials Market, By Trial Design, By Region, 2023-2030 (US$ Mn)

TABLE 106 GermanyCell & Gene Therapy Clinical Trials Market, by Patient Age, 2017-2022 (US$ Mn)

TABLE 107 GermanyCell & Gene Therapy Clinical Trials Market, by Patient Age, 2023-2030 (US$ Mn)

TABLE 108 France Cell & Gene Therapy Clinical Trials Market, By Therapy Type, 2017-2022 (US$ Mn)

TABLE 109 France Cell & Gene Therapy Clinical Trials Market, By Therapy Type, 2023-2030 (US$ Mn)

TABLE 110 France Cell & Gene Therapy Clinical Trials Market, By Indication, 2017-2022 (US$ Mn)

TABLE 111 France Cell & Gene Therapy Clinical Trials Market, By Indication, 2023-2030 (US$ Mn)

TABLE 112 France Cell & Gene Therapy Clinical Trials Market, By Phase of Clinical Trials, 2017-2022 (US$ Mn)

TABLE 113 France Cell & Gene Therapy Clinical Trials Market, By Phase of Clinical Trials, 2023-2030 (US$ Mn)

TABLE 114 FranceCell & Gene Therapy Clinical Trials Market, By Trial Design, By Region, 2017-2022 (US$ Mn)

TABLE 115 FranceCell & Gene Therapy Clinical Trials Market, By Trial Design, By Region, 2023-2030 (US$ Mn)

TABLE 116 FranceCell & Gene Therapy Clinical Trials Market, by Patient Age, 2017-2022 (US$ Mn)

TABLE 117 FranceCell & Gene Therapy Clinical Trials Market, by Patient Age, 2023-2030 (US$ Mn)

TABLE 118 United Kingdom Cell & Gene Therapy Clinical Trials Market, By Therapy Type, 2017-2022 (US$ Mn)

TABLE 119 United Kingdom Cell & Gene Therapy Clinical Trials Market, By Therapy Type, 2023-2030 (US$ Mn)

TABLE 120 United Kingdom Cell & Gene Therapy Clinical Trials Market, By Indication, 2017-2022 (US$ Mn)

TABLE 121 United Kingdom Cell & Gene Therapy Clinical Trials Market, By Indication, 2023-2030 (US$ Mn)

TABLE 122 United Kingdom Cell & Gene Therapy Clinical Trials Market, By Phase of Clinical Trials, 2017-2022 (US$ Mn)

TABLE 123 United Kingdom Cell & Gene Therapy Clinical Trials Market, By Phase of Clinical Trials, 2023-2030 (US$ Mn)

TABLE 124 United KingdomCell & Gene Therapy Clinical Trials Market, By Trial Design, By Region, 2017-2022 (US$ Mn)

TABLE 125 United KingdomCell & Gene Therapy Clinical Trials Market, By Trial Design, By Region, 2023-2030 (US$ Mn)

TABLE 126 United KingdomCell & Gene Therapy Clinical Trials Market, by Patient Age, 2017-2022 (US$ Mn)

TABLE 127 United KingdomCell & Gene Therapy Clinical Trials Market, by Patient Age, 2023-2030 (US$ Mn)

TABLE 128 Italy Cell & Gene Therapy Clinical Trials Market, By Therapy Type, 2017-2022 (US$ Mn)

TABLE 129 Italy Cell & Gene Therapy Clinical Trials Market, By Therapy Type, 2023-2030 (US$ Mn)

TABLE 130 Italy Cell & Gene Therapy Clinical Trials Market, By Indication, 2017-2022 (US$ Mn)

TABLE 131 Italy Cell & Gene Therapy Clinical Trials Market, By Indication, 2023-2030 (US$ Mn)

TABLE 132 Italy Cell & Gene Therapy Clinical Trials Market, By Phase of Clinical Trials, 2017-2022 (US$ Mn)

TABLE 133 Italy Cell & Gene Therapy Clinical Trials Market, By Phase of Clinical Trials, 2023-2030 (US$ Mn)

TABLE 134 ItalyCell & Gene Therapy Clinical Trials Market, By Trial Design, By Region, 2017-2022 (US$ Mn)

TABLE 135 ItalyCell & Gene Therapy Clinical Trials Market, By Trial Design, By Region, 2023-2030 (US$ Mn)

TABLE 136 ItalyCell & Gene Therapy Clinical Trials Market, by Patient Age, 2017-2022 (US$ Mn)

TABLE 137 ItalyCell & Gene Therapy Clinical Trials Market, by Patient Age, 2023-2030 (US$ Mn)

TABLE 138 Spain Cell & Gene Therapy Clinical Trials Market, By Therapy Type, 2017-2022 (US$ Mn)

TABLE 139 Spain Cell & Gene Therapy Clinical Trials Market, By Therapy Type, 2023-2030 (US$ Mn)

TABLE 140 Spain Cell & Gene Therapy Clinical Trials Market, By Indication, 2017-2022 (US$ Mn)

TABLE 141 Spain Cell & Gene Therapy Clinical Trials Market, By Indication, 2023-2030 (US$ Mn)

TABLE 142 Spain Cell & Gene Therapy Clinical Trials Market, By Phase of Clinical Trials, 2017-2022 (US$ Mn)

TABLE 143 Spain Cell & Gene Therapy Clinical Trials Market, By Phase of Clinical Trials, 2023-2030 (US$ Mn)

TABLE 144 SpainCell & Gene Therapy Clinical Trials Market, By Trial Design, By Region, 2017-2022 (US$ Mn)

TABLE 145 SpainCell & Gene Therapy Clinical Trials Market, By Trial Design, By Region, 2023-2030 (US$ Mn)

TABLE 146 SpainCell & Gene Therapy Clinical Trials Market, by Patient Age, 2017-2022 (US$ Mn)

TABLE 147 SpainCell & Gene Therapy Clinical Trials Market, by Patient Age, 2023-2030 (US$ Mn)

TABLE 148 BeneluxCell & Gene Therapy Clinical Trials Market, By Therapy Type, 2017-2022 (US$ Mn)

TABLE 149 BeneluxCell & Gene Therapy Clinical Trials Market, By Therapy Type, 2023-2030 (US$ Mn)

TABLE 150 BeneluxCell & Gene Therapy Clinical Trials Market, By Indication, 2017-2022 (US$ Mn)

TABLE 151 BeneluxCell & Gene Therapy Clinical Trials Market, By Indication, 2023-2030 (US$ Mn)

TABLE 152 BeneluxCell & Gene Therapy Clinical Trials Market, By Phase of Clinical Trials, 2017-2022 (US$ Mn)

TABLE 153 BeneluxCell & Gene Therapy Clinical Trials Market, By Phase of Clinical Trials, 2023-2030 (US$ Mn)

TABLE 154 BeneluxCell & Gene Therapy Clinical Trials Market, By Trial Design, By Region, 2017-2022 (US$ Mn)

TABLE 155 BeneluxCell & Gene Therapy Clinical Trials Market, By Trial Design, By Region, 2023-2030 (US$ Mn)

TABLE 156 BeneluxCell & Gene Therapy Clinical Trials Market, by Patient Age, 2017-2022 (US$ Mn)

TABLE 157 BeneluxCell & Gene Therapy Clinical Trials Market, by Patient Age, 2023-2030 (US$ Mn)

TABLE 158 RussiaCell & Gene Therapy Clinical Trials Market, By Therapy Type, 2017-2022 (US$ Mn)

TABLE 159 RussiaCell & Gene Therapy Clinical Trials Market, By Therapy Type, 2023-2030 (US$ Mn)

TABLE 160 RussiaCell & Gene Therapy Clinical Trials Market, By Indication, 2017-2022 (US$ Mn)

TABLE 161 RussiaCell & Gene Therapy Clinical Trials Market, By Indication, 2023-2030 (US$ Mn)

TABLE 162 RussiaCell & Gene Therapy Clinical Trials Market, By Phase of Clinical Trials, 2017-2022 (US$ Mn)

TABLE 163 RussiaCell & Gene Therapy Clinical Trials Market, By Phase of Clinical Trials, 2023-2030 (US$ Mn)

TABLE 164 RussiaCell & Gene Therapy Clinical Trials Market, By Trial Design, By Region, 2017-2022 (US$ Mn)

TABLE 165 RussiaCell & Gene Therapy Clinical Trials Market, By Trial Design, By Region, 2023-2030 (US$ Mn)

TABLE 166 RussiaCell & Gene Therapy Clinical Trials Market, by Patient Age, 2017-2022 (US$ Mn)

TABLE 167 RussiaCell & Gene Therapy Clinical Trials Market, by Patient Age, 2023-2030 (US$ Mn)

TABLE 168 Rest of Europe Cell & Gene Therapy Clinical Trials Market, By Therapy Type, 2017-2022 (US$ Mn)

TABLE 169 Rest of Europe Cell & Gene Therapy Clinical Trials Market, By Therapy Type, 2023-2030 (US$ Mn)

TABLE 170 Rest of Europe Cell & Gene Therapy Clinical Trials Market, By Indication, 2017-2022 (US$ Mn)

TABLE 171 Rest of Europe Cell & Gene Therapy Clinical Trials Market, By Indication, 2023-2030 (US$ Mn)

TABLE 172 Rest of Europe Cell & Gene Therapy Clinical Trials Market, By Phase of Clinical Trials, 2017-2022 (US$ Mn)

TABLE 173 Rest of Europe Cell & Gene Therapy Clinical Trials Market, By Phase of Clinical Trials, 2023-2030 (US$ Mn)

TABLE 174 Rest of EuropeCell & Gene Therapy Clinical Trials Market, By Trial Design, By Region, 2017-2022 (US$ Mn)

TABLE 175 Rest of EuropeCell & Gene Therapy Clinical Trials Market, By Trial Design, By Region, 2023-2030 (US$ Mn)

TABLE 176 Rest of EuropeCell & Gene Therapy Clinical Trials Market, by Patient Age, 2017-2022 (US$ Mn)

TABLE 177 Rest of EuropeCell & Gene Therapy Clinical Trials Market, by Patient Age, 2023-2030 (US$ Mn)

TABLE 178 Asia Pacific Cell & Gene Therapy Clinical Trials Market, By Therapy Type, 2017-2022 (US$ Mn)

TABLE 179 Asia Pacific Cell & Gene Therapy Clinical Trials Market, By Therapy Type, 2023-2030 (US$ Mn)

TABLE 180 Asia Pacific Cell & Gene Therapy Clinical Trials Market, By Indication, 2017-2022 (US$ Mn)

TABLE 181 Asia Pacific Cell & Gene Therapy Clinical Trials Market, By Indication, 2023-2030 (US$ Mn)

TABLE 182 Asia Pacific Cell & Gene Therapy Clinical Trials Market, By Phase of Clinical Trials, 2017-2022 (US$ Mn)

TABLE 183 Asia Pacific Cell & Gene Therapy Clinical Trials Market, By Phase of Clinical Trials, 2023-2030 (US$ Mn)

TABLE 184 Asia PacificCell & Gene Therapy Clinical Trials Market, By Trial Design, By Region, 2017-2022 (US$ Mn)

TABLE 185 Asia PacificCell & Gene Therapy Clinical Trials Market, By Trial Design, By Region, 2023-2030 (US$ Mn)

TABLE 186 Asia PacificCell & Gene Therapy Clinical Trials Market, by Patient Age, 2017-2022 (US$ Mn)

TABLE 187 Asia PacificCell & Gene Therapy Clinical Trials Market, by Patient Age, 2023-2030 (US$ Mn)

TABLE 188 China Cell & Gene Therapy Clinical Trials Market, By Therapy Type, 2017-2022 (US$ Mn)

TABLE 189 China Cell & Gene Therapy Clinical Trials Market, By Therapy Type, 2023-2030 (US$ Mn)

TABLE 190 China Cell & Gene Therapy Clinical Trials Market, By Indication, 2017-2022 (US$ Mn)

TABLE 191 China Cell & Gene Therapy Clinical Trials Market, By Indication, 2023-2030 (US$ Mn)

TABLE 192 China Cell & Gene Therapy Clinical Trials Market, By Phase of Clinical Trials, 2017-2022 (US$ Mn)

TABLE 193 China Cell & Gene Therapy Clinical Trials Market, By Phase of Clinical Trials, 2023-2030 (US$ Mn)

TABLE 194 ChinaCell & Gene Therapy Clinical Trials Market, By Trial Design, By Region, 2017-2022 (US$ Mn)

TABLE 195 ChinaCell & Gene Therapy Clinical Trials Market, By Trial Design, By Region, 2023-2030 (US$ Mn)

TABLE 196 ChinaCell & Gene Therapy Clinical Trials Market, by Patient Age, 2017-2022 (US$ Mn)

TABLE 197 ChinaCell & Gene Therapy Clinical Trials Market, by Patient Age, 2023-2030 (US$ Mn)

TABLE 198 Japan Cell & Gene Therapy Clinical Trials Market, By Therapy Type, 2017-2022 (US$ Mn)

TABLE 199 Japan Cell & Gene Therapy Clinical Trials Market, By Therapy Type, 2023-2030 (US$ Mn)

TABLE 200 Japan Cell & Gene Therapy Clinical Trials Market, By Indication, 2017-2022 (US$ Mn)

TABLE 201 Japan Cell & Gene Therapy Clinical Trials Market, By Indication, 2023-2030 (US$ Mn)

TABLE 202 Japan Cell & Gene Therapy Clinical Trials Market, By Phase of Clinical Trials, 2017-2022 (US$ Mn)

TABLE 203 Japan Cell & Gene Therapy Clinical Trials Market, By Phase of Clinical Trials, 2023-2030 (US$ Mn)

TABLE 204 JapanCell & Gene Therapy Clinical Trials Market, By Trial Design, By Region, 2017-2022 (US$ Mn)

TABLE 205 JapanCell & Gene Therapy Clinical Trials Market, By Trial Design, By Region, 2023-2030 (US$ Mn)

TABLE 206 JapanCell & Gene Therapy Clinical Trials Market, by Patient Age, 2017-2022 (US$ Mn)

TABLE 207 JapanCell & Gene Therapy Clinical Trials Market, by Patient Age, 2023-2030 (US$ Mn)

TABLE 208 India Cell & Gene Therapy Clinical Trials Market, By Therapy Type, 2017-2022 (US$ Mn)

TABLE 209 India Cell & Gene Therapy Clinical Trials Market, By Therapy Type, 2023-2030 (US$ Mn)

TABLE 210 India Cell & Gene Therapy Clinical Trials Market, By Indication, 2017-2022 (US$ Mn)

TABLE 211 India Cell & Gene Therapy Clinical Trials Market, By Indication, 2023-2030 (US$ Mn)

TABLE 212 India Cell & Gene Therapy Clinical Trials Market, By Phase of Clinical Trials, 2017-2022 (US$ Mn)

TABLE 213 India Cell & Gene Therapy Clinical Trials Market, By Phase of Clinical Trials, 2023-2030 (US$ Mn)

TABLE 214 IndiaCell & Gene Therapy Clinical Trials Market, By Trial Design, By Region, 2017-2022 (US$ Mn)

TABLE 215 IndiaCell & Gene Therapy Clinical Trials Market, By Trial Design, By Region, 2023-2030 (US$ Mn)

TABLE 216 IndiaCell & Gene Therapy Clinical Trials Market, by Patient Age, 2017-2022 (US$ Mn)

TABLE 217 IndiaCell & Gene Therapy Clinical Trials Market, by Patient Age, 2023-2030 (US$ Mn)

TABLE 218 South Korea Cell & Gene Therapy Clinical Trials Market, By Therapy Type, 2017-2022 (US$ Mn)

TABLE 219 South Korea Cell & Gene Therapy Clinical Trials Market, By Therapy Type, 2023-2030 (US$ Mn)

TABLE 220 South Korea Cell & Gene Therapy Clinical Trials Market, By Indication, 2017-2022 (US$ Mn)

TABLE 221 South Korea Cell & Gene Therapy Clinical Trials Market, By Indication, 2023-2030 (US$ Mn)

TABLE 222 South Korea Cell & Gene Therapy Clinical Trials Market, By Phase of Clinical Trials, 2017-2022 (US$ Mn)

TABLE 223 South Korea Cell & Gene Therapy Clinical Trials Market, By Phase of Clinical Trials, 2023-2030 (US$ Mn)

TABLE 224 South KoreaCell & Gene Therapy Clinical Trials Market, By Trial Design, By Region, 2017-2022 (US$ Mn)

TABLE 225 South KoreaCell & Gene Therapy Clinical Trials Market, By Trial Design, By Region, 2023-2030 (US$ Mn)

TABLE 226 South KoreaCell & Gene Therapy Clinical Trials Market, by Patient Age, 2017-2022 (US$ Mn)

TABLE 227 South KoreaCell & Gene Therapy Clinical Trials Market, by Patient Age, 2023-2030 (US$ Mn)

TABLE 228 South-East Asia Cell & Gene Therapy Clinical Trials Market, By Therapy Type, 2017-2022 (US$ Mn)

TABLE 229 South-East Asia Cell & Gene Therapy Clinical Trials Market, By Therapy Type, 2023-2030 (US$ Mn)

TABLE 230 South-East Asia Cell & Gene Therapy Clinical Trials Market, By Indication, 2017-2022 (US$ Mn)

TABLE 231 South-East Asia Cell & Gene Therapy Clinical Trials Market, By Indication, 2023-2030 (US$ Mn)

TABLE 232 South-East Asia Cell & Gene Therapy Clinical Trials Market, By Phase of Clinical Trials, 2017-2022 (US$ Mn)

TABLE 233 South-East Asia Cell & Gene Therapy Clinical Trials Market, By Phase of Clinical Trials, 2023-2030 (US$ Mn)

TABLE 234 South-East AsiaCell & Gene Therapy Clinical Trials Market, By Trial Design, By Region, 2017-2022 (US$ Mn)

TABLE 235 South-East AsiaCell & Gene Therapy Clinical Trials Market, By Trial Design, By Region, 2023-2030 (US$ Mn)

TABLE 236 South-East AsiaCell & Gene Therapy Clinical Trials Market, by Patient Age, 2017-2022 (US$ Mn)

TABLE 237 South-East AsiaCell & Gene Therapy Clinical Trials Market, by Patient Age, 2023-2030 (US$ Mn)

TABLE 238 Rest of Asia Pacific Cell & Gene Therapy Clinical Trials Market, By Therapy Type, 2017-2022 (US$ Mn)

TABLE 239 Rest of Asia Pacific Cell & Gene Therapy Clinical Trials Market, By Therapy Type, 2023-2030 (US$ Mn)

TABLE 240 Rest of Asia Pacific Cell & Gene Therapy Clinical Trials Market, By Indication, 2017-2022 (US$ Mn)

TABLE 241 Rest of Asia Pacific Cell & Gene Therapy Clinical Trials Market, By Indication, 2023-2030 (US$ Mn)

TABLE 242 Rest of Asia Pacific Cell & Gene Therapy Clinical Trials Market, By Phase of Clinical Trials, 2017-2022 (US$ Mn)

TABLE 243 Rest of Asia Pacific Cell & Gene Therapy Clinical Trials Market, By Phase of Clinical Trials, 2023-2030 (US$ Mn)

TABLE 244 Rest of Asia PacificCell & Gene Therapy Clinical Trials Market, By Trial Design, By Region, 2017-2022 (US$ Mn)

TABLE 245 Rest of Asia PacificCell & Gene Therapy Clinical Trials Market, By Trial Design, By Region, 2023-2030 (US$ Mn)

TABLE 246 Rest of Asia PacificCell & Gene Therapy Clinical Trials Market, by Patient Age, 2017-2022 (US$ Mn)

TABLE 247 Rest of Asia PacificCell & Gene Therapy Clinical Trials Market, by Patient Age, 2023-2030 (US$ Mn)

TABLE 248 Latin America Cell & Gene Therapy Clinical Trials Market, By Therapy Type, 2017-2022 (US$ Mn)

TABLE 249 Latin America Cell & Gene Therapy Clinical Trials Market, By Therapy Type, 2023-2030 (US$ Mn)

TABLE 250 Latin America Cell & Gene Therapy Clinical Trials Market, By Indication, 2017-2022 (US$ Mn)

TABLE 251 Latin America Cell & Gene Therapy Clinical Trials Market, By Indication, 2023-2030 (US$ Mn)

TABLE 252 Latin America Cell & Gene Therapy Clinical Trials Market, By Phase of Clinical Trials, 2017-2022 (US$ Mn)

TABLE 253 Latin America Cell & Gene Therapy Clinical Trials Market, By Phase of Clinical Trials, 2023-2030 (US$ Mn)

TABLE 254 Latin AmericaCell & Gene Therapy Clinical Trials Market, By Trial Design, By Region, 2017-2022 (US$ Mn)

TABLE 255 Latin AmericaCell & Gene Therapy Clinical Trials Market, By Trial Design, By Region, 2023-2030 (US$ Mn)

TABLE 256 Latin AmericaCell & Gene Therapy Clinical Trials Market, by Patient Age, 2017-2022 (US$ Mn)

TABLE 257 Latin AmericaCell & Gene Therapy Clinical Trials Market, by Patient Age, 2023-2030 (US$ Mn)

TABLE 258 Brazil Cell & Gene Therapy Clinical Trials Market, By Therapy Type, 2017-2022 (US$ Mn)

TABLE 259 Brazil Cell & Gene Therapy Clinical Trials Market, By Therapy Type, 2023-2030 (US$ Mn)

TABLE 260 Brazil Cell & Gene Therapy Clinical Trials Market, By Indication, 2017-2022 (US$ Mn)

TABLE 261 Brazil Cell & Gene Therapy Clinical Trials Market, By Indication, 2023-2030 (US$ Mn)

TABLE 262 Brazil Cell & Gene Therapy Clinical Trials Market, By Phase of Clinical Trials, 2017-2022 (US$ Mn)

TABLE 263 Brazil Cell & Gene Therapy Clinical Trials Market, By Phase of Clinical Trials, 2023-2030 (US$ Mn)

TABLE 264 BrazilCell & Gene Therapy Clinical Trials Market, By Trial Design, By Region, 2017-2022 (US$ Mn)

TABLE 265 BrazilCell & Gene Therapy Clinical Trials Market, By Trial Design, By Region, 2023-2030 (US$ Mn)

TABLE 266 BrazilCell & Gene Therapy Clinical Trials Market, by Patient Age, 2017-2022 (US$ Mn)

TABLE 267 BrazilCell & Gene Therapy Clinical Trials Market, by Patient Age, 2023-2030 (US$ Mn)

TABLE 268 Argentina Cell & Gene Therapy Clinical Trials Market, By Therapy Type, 2017-2022 (US$ Mn)

TABLE 269 Argentina Cell & Gene Therapy Clinical Trials Market, By Therapy Type, 2023-2030 (US$ Mn)

TABLE 270 Argentina Cell & Gene Therapy Clinical Trials Market, By Indication, 2017-2022 (US$ Mn)

TABLE 271 Argentina Cell & Gene Therapy Clinical Trials Market, By Indication, 2023-2030 (US$ Mn)

TABLE 272 Argentina Cell & Gene Therapy Clinical Trials Market, By Phase of Clinical Trials, 2017-2022 (US$ Mn)

TABLE 273 Argentina Cell & Gene Therapy Clinical Trials Market, By Phase of Clinical Trials, 2023-2030 (US$ Mn)

TABLE 274 ArgentinaCell & Gene Therapy Clinical Trials Market, By Trial Design, By Region, 2017-2022 (US$ Mn)

TABLE 275 ArgentinaCell & Gene Therapy Clinical Trials Market, By Trial Design, By Region, 2023-2030 (US$ Mn)

TABLE 276 ArgentinaCell & Gene Therapy Clinical Trials Market, by Patient Age, 2017-2022 (US$ Mn)

TABLE 277 ArgentinaCell & Gene Therapy Clinical Trials Market, by Patient Age, 2023-2030 (US$ Mn)

TABLE 278 Rest of Latin America Cell & Gene Therapy Clinical Trials Market, By Therapy Type, 2017-2022 (US$ Mn)

TABLE 279 Rest of Latin America Cell & Gene Therapy Clinical Trials Market, By Therapy Type, 2023-2030 (US$ Mn)

TABLE 280 Rest of Latin America Cell & Gene Therapy Clinical Trials Market, By Indication, 2017-2022 (US$ Mn)

TABLE 281 Rest of Latin America Cell & Gene Therapy Clinical Trials Market, By Indication, 2023-2030 (US$ Mn)

TABLE 282 Rest of Latin America Cell & Gene Therapy Clinical Trials Market, By Phase of Clinical Trials, 2017-2022 (US$ Mn)

TABLE 283 Rest of Latin America Cell & Gene Therapy Clinical Trials Market, By Phase of Clinical Trials, 2023-2030 (US$ Mn)

TABLE 284 Rest of Latin AmericaCell & Gene Therapy Clinical Trials Market, By Trial Design, By Region, 2017-2022 (US$ Mn)

TABLE 285 Rest of Latin AmericaCell & Gene Therapy Clinical Trials Market, By Trial Design, By Region, 2023-2030 (US$ Mn)

TABLE 286 Rest of Latin AmericaCell & Gene Therapy Clinical Trials Market, by Patient Age, 2017-2022 (US$ Mn)

TABLE 287 Rest of Latin AmericaCell & Gene Therapy Clinical Trials Market, by Patient Age, 2023-2030 (US$ Mn)

TABLE 288 Middle EastCell & Gene Therapy Clinical Trials Market, By Therapy Type, 2017-2022 (US$ Mn)

TABLE 289 Middle EastCell & Gene Therapy Clinical Trials Market, By Therapy Type, 2023-2030 (US$ Mn)

TABLE 290 Middle EastCell & Gene Therapy Clinical Trials Market, By Indication, 2017-2022 (US$ Mn)

TABLE 291 Middle EastCell & Gene Therapy Clinical Trials Market, By Indication, 2023-2030 (US$ Mn)

TABLE 292 Middle EastCell & Gene Therapy Clinical Trials Market, By Phase of Clinical Trials, 2017-2022 (US$ Mn)

TABLE 293 Middle EastCell & Gene Therapy Clinical Trials Market, By Phase of Clinical Trials, 2023-2030 (US$ Mn)

TABLE 294 Middle EastCell & Gene Therapy Clinical Trials Market, By Trial Design, By Region, 2017-2022 (US$ Mn)

TABLE 295 Middle EastCell & Gene Therapy Clinical Trials Market, By Trial Design, By Region, 2023-2030 (US$ Mn)

TABLE 296 Middle EastCell & Gene Therapy Clinical Trials Market, by Patient Age, 2017-2022 (US$ Mn)

TABLE 297 Middle EastCell & Gene Therapy Clinical Trials Market, by Patient Age, 2023-2030 (US$ Mn)

TABLE 298 UAECell & Gene Therapy Clinical Trials Market, By Therapy Type, 2017-2022 (US$ Mn)

TABLE 299 UAECell & Gene Therapy Clinical Trials Market, By Therapy Type, 2023-2030 (US$ Mn)

TABLE 300 UAECell & Gene Therapy Clinical Trials Market, By Indication, 2017-2022 (US$ Mn)

TABLE 301 UAECell & Gene Therapy Clinical Trials Market, By Indication, 2023-2030 (US$ Mn)

TABLE 302 UAECell & Gene Therapy Clinical Trials Market, By Phase of Clinical Trials, 2017-2022 (US$ Mn)

TABLE 303 UAECell & Gene Therapy Clinical Trials Market, By Phase of Clinical Trials, 2023-2030 (US$ Mn)

TABLE 304 UAECell & Gene Therapy Clinical Trials Market, By Trial Design, By Region, 2017-2022 (US$ Mn)

TABLE 305 UAECell & Gene Therapy Clinical Trials Market, By Trial Design, By Region, 2023-2030 (US$ Mn)

TABLE 306 UAECell & Gene Therapy Clinical Trials Market, by Patient Age, 2017-2022 (US$ Mn)

TABLE 307 UAECell & Gene Therapy Clinical Trials Market, by Patient Age, 2023-2030 (US$ Mn)

TABLE 308 Saudi ArabiaCell & Gene Therapy Clinical Trials Market, By Therapy Type, 2017-2022 (US$ Mn)

TABLE 309 Saudi ArabiaCell & Gene Therapy Clinical Trials Market, By Therapy Type, 2023-2030 (US$ Mn)

TABLE 310 Saudi ArabiaCell & Gene Therapy Clinical Trials Market, By Indication, 2017-2022 (US$ Mn)

TABLE 311 Saudi ArabiaCell & Gene Therapy Clinical Trials Market, By Indication, 2023-2030 (US$ Mn)

TABLE 312 Saudi ArabiaCell & Gene Therapy Clinical Trials Market, By Phase of Clinical Trials, 2017-2022 (US$ Mn)

TABLE 313 Saudi ArabiaCell & Gene Therapy Clinical Trials Market, By Phase of Clinical Trials, 2023-2030 (US$ Mn)

TABLE 314 Saudi ArabiaCell & Gene Therapy Clinical Trials Market, By Trial Design, By Region, 2017-2022 (US$ Mn)

TABLE 315 Saudi ArabiaCell & Gene Therapy Clinical Trials Market, By Trial Design, By Region, 2023-2030 (US$ Mn)

TABLE 316 Saudi ArabiaCell & Gene Therapy Clinical Trials Market, by Patient Age, 2017-2022 (US$ Mn)

TABLE 317 Saudi ArabiaCell & Gene Therapy Clinical Trials Market, by Patient Age, 2023-2030 (US$ Mn)

TABLE 318 Rest of Middle EastCell & Gene Therapy Clinical Trials Market, By Therapy Type, 2017-2022 (US$ Mn)

TABLE 319 Rest of Middle EastCell & Gene Therapy Clinical Trials Market, By Therapy Type, 2023-2030 (US$ Mn)

TABLE 320 Rest of Middle EastCell & Gene Therapy Clinical Trials Market, By Indication, 2017-2022 (US$ Mn)

TABLE 321 Rest of Middle EastCell & Gene Therapy Clinical Trials Market, By Indication, 2023-2030 (US$ Mn)

TABLE 322 Rest of Middle EastCell & Gene Therapy Clinical Trials Market, By Phase of Clinical Trials, 2017-2022 (US$ Mn)

TABLE 323 Rest of Middle EastCell & Gene Therapy Clinical Trials Market, By Phase of Clinical Trials, 2023-2030 (US$ Mn)

TABLE 324 Rest of Middle EastCell & Gene Therapy Clinical Trials Market, By Trial Design, By Region, 2017-2022 (US$ Mn)

TABLE 325 Rest of Middle EastCell & Gene Therapy Clinical Trials Market, By Trial Design, By Region, 2023-2030 (US$ Mn)

TABLE 326 Rest of Middle EastCell & Gene Therapy Clinical Trials Market, by Patient Age, 2017-2022 (US$ Mn)

TABLE 327 Rest of Middle EastCell & Gene Therapy Clinical Trials Market, by Patient Age, 2023-2030 (US$ Mn)

TABLE 328 AfricaCell & Gene Therapy Clinical Trials Market, By Therapy Type, 2017-2022 (US$ Mn)

TABLE 329 AfricaCell & Gene Therapy Clinical Trials Market, By Therapy Type, 2023-2030 (US$ Mn)

TABLE 330 AfricaCell & Gene Therapy Clinical Trials Market, By Indication, 2017-2022 (US$ Mn)

TABLE 331 AfricaCell & Gene Therapy Clinical Trials Market, By Indication, 2023-2030 (US$ Mn)

TABLE 332 AfricaCell & Gene Therapy Clinical Trials Market, By Phase of Clinical Trials, 2017-2022 (US$ Mn)

TABLE 333 AfricaCell & Gene Therapy Clinical Trials Market, By Phase of Clinical Trials, 2023-2030 (US$ Mn)

TABLE 334 AfricaCell & Gene Therapy Clinical Trials Market, By Trial Design, By Region, 2017-2022 (US$ Mn)

TABLE 335 AfricaCell & Gene Therapy Clinical Trials Market, By Trial Design, By Region, 2023-2030 (US$ Mn)

TABLE 336 AfricaCell & Gene Therapy Clinical Trials Market, by Patient Age, 2017-2022 (US$ Mn)

TABLE 337 AfricaCell & Gene Therapy Clinical Trials Market, by Patient Age, 2023-2030 (US$ Mn)

TABLE 338 South AfricaCell & Gene Therapy Clinical Trials Market, By Therapy Type, 2017-2022 (US$ Mn)

TABLE 339 South AfricaCell & Gene Therapy Clinical Trials Market, By Therapy Type, 2023-2030 (US$ Mn)

TABLE 340 South AfricaCell & Gene Therapy Clinical Trials Market, By Indication, 2017-2022 (US$ Mn)

TABLE 341 South AfricaCell & Gene Therapy Clinical Trials Market, By Indication, 2023-2030 (US$ Mn)

TABLE 342 South AfricaCell & Gene Therapy Clinical Trials Market, By Phase of Clinical Trials, 2017-2022 (US$ Mn)

TABLE 343 South AfricaCell & Gene Therapy Clinical Trials Market, By Phase of Clinical Trials, 2023-2030 (US$ Mn)

TABLE 344 South AfricaCell & Gene Therapy Clinical Trials Market, By Trial Design, By Region, 2017-2022 (US$ Mn)

TABLE 345 South AfricaCell & Gene Therapy Clinical Trials Market, By Trial Design, By Region, 2023-2030 (US$ Mn)

TABLE 346 South AfricaCell & Gene Therapy Clinical Trials Market, by Patient Age, 2017-2022 (US$ Mn)

TABLE 347 South AfricaCell & Gene Therapy Clinical Trials Market, by Patient Age, 2023-2030 (US$ Mn)

TABLE 348 EgyptCell & Gene Therapy Clinical Trials Market, By Therapy Type, 2017-2022 (US$ Mn)

TABLE 349 EgyptCell & Gene Therapy Clinical Trials Market, By Therapy Type, 2023-2030 (US$ Mn)

TABLE 350 EgyptCell & Gene Therapy Clinical Trials Market, By Indication, 2017-2022 (US$ Mn)

TABLE 351 EgyptCell & Gene Therapy Clinical Trials Market, By Indication, 2023-2030 (US$ Mn)

TABLE 352 EgyptCell & Gene Therapy Clinical Trials Market, By Phase of Clinical Trials, 2017-2022 (US$ Mn)

TABLE 353 EgyptCell & Gene Therapy Clinical Trials Market, By Phase of Clinical Trials, 2023-2030 (US$ Mn)

TABLE 354 EgyptCell & Gene Therapy Clinical Trials Market, By Trial Design, By Region, 2017-2022 (US$ Mn)

TABLE 355 EgyptCell & Gene Therapy Clinical Trials Market, By Trial Design, By Region, 2023-2030 (US$ Mn)

TABLE 356 EgyptCell & Gene Therapy Clinical Trials Market, by Patient Age, 2017-2022 (US$ Mn)

TABLE 357 EgyptCell & Gene Therapy Clinical Trials Market, by Patient Age, 2023-2030 (US$ Mn)

TABLE 358 Rest of AfricaCell & Gene Therapy Clinical Trials Market, By Therapy Type, 2017-2022 (US$ Mn)

TABLE 359 Rest of AfricaCell & Gene Therapy Clinical Trials Market, By Therapy Type, 2023-2030 (US$ Mn)

TABLE 360 Rest of AfricaCell & Gene Therapy Clinical Trials Market, By Indication, 2017-2022 (US$ Mn)

TABLE 361 Rest of AfricaCell & Gene Therapy Clinical Trials Market, By Indication, 2023-2030 (US$ Mn)

TABLE 362 Rest of AfricaCell & Gene Therapy Clinical Trials Market, By Phase of Clinical Trials, 2017-2022 (US$ Mn)

TABLE 363 Rest of AfricaCell & Gene Therapy Clinical Trials Market, By Phase of Clinical Trials, 2023-2030 (US$ Mn)

TABLE 364 Rest of AfricaCell & Gene Therapy Clinical Trials Market, By Trial Design, By Region, 2017-2022 (US$ Mn)

TABLE 365 Rest of AfricaCell & Gene Therapy Clinical Trials Market, By Trial Design, By Region, 2023-2030 (US$ Mn)

TABLE 366 Rest of AfricaCell & Gene Therapy Clinical Trials Market, by Patient Age, 2017-2022 (US$ Mn)

TABLE 367 Rest of AfricaCell & Gene Therapy Clinical Trials Market, by Patient Age, 2023-2030 (US$ Mn)

Frequently asked questions

What is the current size of the global Cell & Gene Therapy Clinical Trials Market?

The global Cell & Gene Therapy Clinical Trials Market was valued at USD 8354.9 Million in 2022.

What is the expected growth rate of the Cell & Gene Therapy Clinical Trials Market between 2023 and 2030?

The Cell & Gene Therapy Clinical Trials Market is expected to grow at a CAGR of 15.30% between 2023 and 2030, reaching USD 26096.1 Million in 2030.

Which segment is leading the market share in terms of Phase of clinical trial?

The phase II category dominated the global market in 2022, accounting for more than 53% of total revenue, as the majority of cell and gene therapies are in this stage of the clinical trial

Which Patient Age segment governs the demand for Cell & Gene Therapy Clinical Trialss in the world?

Adult Patients are the sector with the biggest market demand in the Cell & Gene Therapy Clinical Trials Market

Which Trial Design segment is expected to post the highest CAGR during the forecast period?

Randomized Controlled Trials (RCTs) sector has a higher Compound Annual Growth Rate (CAGR)

Which region is fueling the growth of the Cell & Gene Therapy Clinical Trials industry?

In 2022, North America holds a considerable portion of the Cell & Gene Therapy Clinical Trials Market, accounting for over 48% of the market.

Who are the major players in the global Cell & Gene Therapy Clinical Trials Market?

The top players include IQVIA; ICON Plc; Charles River Laboratories International, Inc.; PAREXEL International Corp.; Laboratory Corporation of America Holdings; Syneos Health; Novotech; Medpace, Holdings, Inc.; PPD Inc.; Veristat, LLC, and others.

What are the major market drivers of the Cell & Gene Therapy Clinical Trials industry?

The primary drivers of the market include rising private and public investments, an increase in the prevalence of cardiovascular illness, and advancements in gene editing and cell therapy technologies.

What are the major market restraints of the Cell & Gene Therapy Clinical Trials industry?

Stringent regulatory requirements, high research and development expenditures, and limited scalability and production constraints

What are the major market opportunities of the Cell & Gene Therapy Clinical Trials industry?

The market’s significant opportunities include expanding applications in numerous therapeutic areas, rising demand for personalized medicine, and the potential for international collaborations and partnerships.

Related Reports

Handheld Surgical Instruments Market

Published:
Report ID: 37153

Lung Biopsy Market

Published:
Report ID: 37131

Mammography Market

Published:
Report ID: 37075

Temperature Controlled Pharma Packaging Solutions Market

Published:
Report ID: 20599

Vietnam Pneumococcal Vaccine Market

Published:
Report ID: 37015

Head and Neck Cancer Market

Published:
Report ID: 36992

Disposable Surgical Devices Market

Published:
Report ID: 36989

Ophthalmoscopes Market

Published:
Report ID: 36972

Japan Restorative Dentistry Market

Published:
Report ID: 36960

India Traditional Medicine Market

Published:
Report ID: 36954

India Restorative Dentistry Market

Published:
Report ID: 36951

Wearable Injectors Market

Published:
Report ID: 36911

Purchase Options

$2999
Delivery Format: Excel.
$4999
Designed for the individual purchaser.
$6999
Users located at a single corporate site or regional office.
$7999
Allowed for unlimited sharing globally within one company.

Request Free Sample

Smallform of Sample request

Have a question?

User Profile

Don’t settle for less – trust Mitul to help you find the best solution.

Call: +91 6232 49 3207

EMAIL MITUL

Report delivery within 24 to 48 hours

– Other Info –

–What people say?-

User Review

I am very impressed with the information in this report. The author clearly did their research when they came up with this product and it has already given me a lot of ideas.

Jana Schmidt
CEDAR CX Technologies

– Connect with us –

Phone

+91 6232 49 3207

support

24/7 Research Support

sales@credenceresearch.com

– Research Methodology –

Going beyond the basics: advanced techniques in research methodology

Get Methodology

– Trusted By –

Pepshi, LG, Nestle
Motorola, Honeywell, Johnson and johnson
LG Chem, SIEMENS, Pfizer
Unilever, Samsonite, QIAGEN
Request Free Sample